Search Results - "CHUNLIN QIAN"
-
1
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
Published in The Lancet (British edition) (19-08-2000)“…We aimed to assess in patients with congestive heart failure whether dual inhibition of neutral endopeptidase and angiotensin-converting enzyme (ACE) with the…”
Get full text
Journal Article -
2
Lower Risk of Major Cardiovascular Events Associated with Adherence to Colesevelam HCI
Published in Pharmacotherapy (01-10-2013)“…Study Objective To examine the relationship between adherence to colesevelam and the risk of major cardiovascular events (acute myocardial infarction [AMI] and…”
Get full text
Journal Article -
3
Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: Results of the conduit hemodynamics of omapatrilat international research study
Published in Circulation (New York, N.Y.) (25-06-2002)“…Increased pulse pressure, an indicator of conduit vessel stiffness, is a strong independent predictor of cardiovascular events in hypertensive cohorts, which…”
Get full text
Journal Article -
4
Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network
Published in Current medical research and opinion (01-12-2013)“…Abstract Objective: To examine outcomes associated with colesevelam treatment among patients with hypercholesterolemia in real-world clinical practice…”
Get full text
Journal Article -
5
Management of Hypertension in Patients With Diabetes Using an Amlodipine-, Olmesartan Medoxomil-, and Hydrochlorothiazide-Based Titration Regimen
Published in The American journal of cardiology (01-05-2011)“…The safety and efficacy of an amlodipine/olmesartan medoxomil (OM)-based titration regimen was assessed in patients with type 2 diabetes mellitus and…”
Get full text
Journal Article -
6
Blood Pressure Outcomes in Patients Receiving Angiotensin II Receptor Blockers in Primary Care: A Comparative Effectiveness Analysis From Electronic Medical Record Data
Published in The journal of clinical hypertension (Greenwich, Conn.) (01-11-2011)“…J Clin Hypertens (Greenwich). 2011;13:801–812. ©2011 Wiley Periodicals, Inc. The authors examined the comparative effectiveness of 4 angiotensin receptor…”
Get full text
Journal Article -
7
Characterization of Health Care Resource Utilization Among Commercially Insured Relapsed Acute Myeloid Leukemia Patients in the United States
Published in Blood (29-11-2018)“…Introduction Relapsed acute myeloid leukemia (AML) patients have poor prognosis and few treatment options. Limited data exists on the economic burden of…”
Get full text
Journal Article -
8
The Triples Distance for Rooted Bifurcating Phylogenetic Trees
Published in Systematic biology (01-09-1996)“…We investigated the triples distance as a measure of the distance between two rooted bifurcating phylogenetic trees. The triples distance counts the number of…”
Get full text
Journal Article -
9
Small Molecular Inhibitors That Target ATM for Drug Discovery: Current Research and Potential Prospective
Published in Journal of medicinal chemistry (12-09-2024)“…The protein kinase ataxia telangiectasia mutated (ATM) is a constituent of the phosphatidylinositol 3-kinase-related kinase (PIKK) family, exerting a pivotal…”
Get full text
Journal Article -
10
Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure
Published in The American journal of cardiology (01-09-2002)“…Angiotensin-converting enzyme (ACE) inhibitors exert their effects by modulating the neurohumoral milieu. Vasopeptidase inhibitors (VPI) are ACE and neutral…”
Get full text
Journal Article -
11
Real World Outcomes of Ferric Carboxymaltose and Ferumoxytol Iron Replacement Therapy: A Retrospective Analysis of Electronic Health Records
Published in Blood (08-12-2017)“…Introduction: Iron deficiency anemia is the most common cause of anemia in the US and it is often observed in patients with chronic diseases and inflammation…”
Get full text
Journal Article -
12
Treatment patterns and cost of care in commercially insured relapsed acute myeloid leukemia (AML) patients in the outpatient setting
Published in Journal of clinical oncology (20-09-2019)“…Abstract only 99 Background: Outpatient administration of cancer therapy has become more common in recent years. The objective of this study was to evaluate…”
Get full text
Journal Article -
13
Similar cities, but diverse carbon controls: Inspiration from the Yangtze River Delta megacity cluster in China
Published in The Science of the total environment (15-12-2023)“…Addressing global uneven urban development and the urgent need to reduce carbon emissions (CE), this study presents a new method for calculating urban…”
Get full text
Journal Article -
14
Research and development factor mismatch, production losses, and energy efficiency: A study on Chinese regional economies
Published in Journal of cleaner production (10-04-2024)“…In the face of global economic development and increasing energy demands, the efficient allocation of Research and Development (R&D) resources emerges as a…”
Get full text
Journal Article -
15
Treatment patterns of tenosynovial giant cell tumor among commercially insured patients: A retrospective claims analysis
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
16
Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects
Published in Journal of the American College of Cardiology (19-06-2002)“…We investigated the acute and long-term hemodynamic and neurohumoral effects of the vasopeptidase inhibitor omapatrilat in human heart failure…”
Get full text
Journal Article -
17
Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States
Published in Pain medicine (Malden, Mass.) (01-11-2015)“…Objective Approximately one third of patients with diabetic peripheral neuropathy (DPN) also experience neuropathic pain, resulting in a significant health…”
Get full text
Journal Article -
18
Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib
Published in The oncologist (Dayton, Ohio) (06-04-2023)“…Abstract Adagrasib (MRTX849) is a KRASG12C inhibitor with favorable properties, including long half-life (23 h), dose-dependent pharmacokinetics, and central…”
Get full text
Journal Article -
19
Practical Guidance for the Management of Adverse Events in Patients with [KRAS.sup.G12C]-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib
Published in The oncologist (Dayton, Ohio) (01-04-2023)“…Adagrasib (MRTX849) is a [KRAS.sup.G12C] inhibitor with favorable properties, including long half-life (23 h), dose-dependent pharmacokinetics, and central…”
Get full text
Journal Article -
20
Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States
Published in Journal of managed care & specialty pharmacy (01-03-2016)“…Fibromyalgia (FM) affects up to 6% of U.S. adults, resulting in a significant burden on the health care system and poor quality of life for patients…”
Get full text
Journal Article